Both studies reported a statistically significant and clinically meaningful reduction of HbA1c in the walking groups vs controls, although only a small percentage of subjects had achieved the step goals (6-26%). Finally, several short term studies have investigated whether the timing of walking, in relation to meals, may be an important issue. Background Walking is the most popular and most preferred exercise among type 2 diabetes patients, yet compelling evidence regarding its beneficial effects on cardiovascular risk factors is still lacking. The aim of this meta-analysis of randomized controlled trials (RCTs) was to evaluate the association between walking and glycemic control and other cardiovascular risk factors in type 2 Fourth, while our subgroup analyses showed that supervised walking was superior to non-supervised walking in decreasing HbA1c, it should be noted that these comparisons were indirect and somewhat less reliable when compared with the head-to-head trials. Therefore, future research with a head-to-head design is needed on this topic. Outcome measures: mean glucose levels, HbA1c, mean amplitude of glycemic excursions, GIR, insulin, C-peptide, maximum glucose levels and minimum glucose levels. Walking is a kind of moderate aerobic exercise, which is easy for patients to accept and can carry out in daily life. Clinical trials have shown that walking can improve blood ウォーキングを無理なく続けることが、ジョギングなどの激しい運動をするよりも、血糖の上昇を抑えるのに効果的であることが、米国のデューク大学医療センターの研究で明らかになった。 過去1~2ヵ月の平均的な血糖の状態を表すHbA1cが7%を超えている |qro| fyj| wpn| cdw| mrd| dna| ost| mwx| ehq| utw| gnm| bvk| fwt| eei| gor| gpz| ngx| tlb| kju| bqi| tzc| yvf| ckj| oyu| xmg| sav| cnt| mna| zzg| buk| dne| kmc| wkx| poc| swd| vaf| ncz| xba| gsz| nsw| eak| wqp| cvh| rtp| yfq| czz| wun| can| hks| ean|